{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Virologie : Questions médicales les plus fréquentes",
"headline": "Virologie : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Virologie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-15",
"dateModified": "2025-04-09",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Virologie"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Microbiologie",
"url": "https://questionsmedicales.fr/mesh/D008829",
"about": {
"@type": "MedicalCondition",
"name": "Microbiologie",
"code": {
"@type": "MedicalCode",
"code": "D008829",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "H01.158.273.540"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Virologie",
"alternateName": "Virology",
"code": {
"@type": "MedicalCode",
"code": "D014773",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Anice C Lowen",
"url": "https://questionsmedicales.fr/author/Anice%20C%20Lowen",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology and Immunology, Emory University, Atlanta, Georgia, USA."
}
},
{
"@type": "Person",
"name": "Arturo Casadevall",
"url": "https://questionsmedicales.fr/author/Arturo%20Casadevall",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA."
}
},
{
"@type": "Person",
"name": "Andrew Mehle",
"url": "https://questionsmedicales.fr/author/Andrew%20Mehle",
"affiliation": {
"@type": "Organization",
"name": "Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, Wisconsin, USA."
}
},
{
"@type": "Person",
"name": "Andrew Pekosz",
"url": "https://questionsmedicales.fr/author/Andrew%20Pekosz",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA."
}
},
{
"@type": "Person",
"name": "Felicia Goodrum",
"url": "https://questionsmedicales.fr/author/Felicia%20Goodrum",
"affiliation": {
"@type": "Organization",
"name": "Department of Immunobiology, University of Arizona, Tucson, Arizona, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "A Banff-based histologic chronicity index is associated with graft loss in patients with a kidney transplant and antibody-mediated rejection.",
"datePublished": "2022-11-01",
"url": "https://questionsmedicales.fr/article/36332728",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.kint.2022.09.030"
}
},
{
"@type": "ScholarlyArticle",
"name": "Liver Inclusion Appears to Be Protective Against Graft Loss-Due-to Chronic But Not Acute Rejection Following Intestinal Transplantation.",
"datePublished": "2023-09-14",
"url": "https://questionsmedicales.fr/article/37779512",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/ti.2023.11568"
}
},
{
"@type": "ScholarlyArticle",
"name": "Molecular screening of transitional B cells as a prognostic marker of improved graft outcome and reduced rejection risk in kidney transplant.",
"datePublished": "2024-08-12",
"url": "https://questionsmedicales.fr/article/39192987",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2024.1433832"
}
},
{
"@type": "ScholarlyArticle",
"name": "A lack of an association between COVID-19 vaccination and corneal graft rejection: results of a large multi-country population based study.",
"datePublished": "2022-12-08",
"url": "https://questionsmedicales.fr/article/36481958",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41433-022-02341-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "HLA-DPB1 molecular mismatches are risk factors for acute rejection and low 5-year graft function in first kidney transplants.",
"datePublished": "2022-12-31",
"url": "https://questionsmedicales.fr/article/36461794",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/tan.14911"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Disciplines des sciences naturelles",
"item": "https://questionsmedicales.fr/mesh/D010811"
},
{
"@type": "ListItem",
"position": 3,
"name": "Disciplines des sciences biologiques",
"item": "https://questionsmedicales.fr/mesh/D001690"
},
{
"@type": "ListItem",
"position": 4,
"name": "Biologie",
"item": "https://questionsmedicales.fr/mesh/D001695"
},
{
"@type": "ListItem",
"position": 5,
"name": "Microbiologie",
"item": "https://questionsmedicales.fr/mesh/D008829"
},
{
"@type": "ListItem",
"position": 6,
"name": "Virologie",
"item": "https://questionsmedicales.fr/mesh/D014773"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Virologie - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Virologie",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Virologie",
"description": "Comment diagnostique-t-on une infection virale ?\nQuels tests sont utilisés pour le VIH ?\nQu'est-ce qu'un test PCR ?\nComment identifier une grippe virale ?\nQuels symptômes indiquent une infection virale ?",
"url": "https://questionsmedicales.fr/mesh/D014773?mesh_terms=Graft+Rejection&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Virologie",
"description": "Quels sont les symptômes de l'hépatite virale ?\nComment se manifeste le COVID-19 ?\nQuels signes d'infection par le virus de la varicelle ?\nQuels symptômes d'une infection à rhinovirus ?\nQuels symptômes d'une infection par le virus Ebola ?",
"url": "https://questionsmedicales.fr/mesh/D014773?mesh_terms=Graft+Rejection&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Virologie",
"description": "Comment prévenir l'infection par le VIH ?\nQuelles vaccins pour prévenir la grippe ?\nComment éviter la transmission du COVID-19 ?\nQuelles mesures pour prévenir l'hépatite A ?\nComment prévenir la varicelle ?",
"url": "https://questionsmedicales.fr/mesh/D014773?mesh_terms=Graft+Rejection&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Virologie",
"description": "Quels traitements pour le VIH ?\nComment traiter une grippe ?\nY a-t-il un traitement pour l'hépatite C ?\nComment traiter une infection à coronavirus ?\nQuels sont les traitements pour la varicelle ?",
"url": "https://questionsmedicales.fr/mesh/D014773?mesh_terms=Graft+Rejection&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Virologie",
"description": "Quelles complications de l'hépatite B ?\nQuelles complications du virus Ebola ?\nQuels risques liés à la grippe ?\nQuelles complications du COVID-19 ?\nQuelles complications de la varicelle ?",
"url": "https://questionsmedicales.fr/mesh/D014773?mesh_terms=Graft+Rejection&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Virologie",
"description": "Quels sont les facteurs de risque pour le VIH ?\nQui est à risque de grippe sévère ?\nQuels facteurs augmentent le risque d'hépatite C ?\nQuels sont les facteurs de risque pour le COVID-19 ?\nQui est à risque de varicelle ?",
"url": "https://questionsmedicales.fr/mesh/D014773?mesh_terms=Graft+Rejection&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on une infection virale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests PCR, sérologiques et parfois des cultures virales."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le VIH ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests de dépistage incluent les tests ELISA et les tests de charge virale."
}
},
{
"@type": "Question",
"name": "Qu'est-ce qu'un test PCR ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est un test qui amplifie l'ADN viral pour détecter la présence de virus."
}
},
{
"@type": "Question",
"name": "Comment identifier une grippe virale ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests rapides et des cultures de virus peuvent confirmer une grippe."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une infection virale ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, fatigue, douleurs musculaires et symptômes respiratoires sont courants."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de l'hépatite virale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Jaunisse, fatigue, douleurs abdominales et perte d'appétit sont fréquents."
}
},
{
"@type": "Question",
"name": "Comment se manifeste le COVID-19 ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, toux, essoufflement et perte de goût sont des symptômes clés."
}
},
{
"@type": "Question",
"name": "Quels signes d'infection par le virus de la varicelle ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éruption cutanée, démangeaisons et fièvre sont typiques de la varicelle."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une infection à rhinovirus ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Congestion nasale, éternuements et maux de gorge sont courants."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une infection par le virus Ebola ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, vomissements, diarrhée et hémorragies peuvent se manifester."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'infection par le VIH ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des préservatifs et des traitements prophylactiques comme le PrEP."
}
},
{
"@type": "Question",
"name": "Quelles vaccins pour prévenir la grippe ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le vaccin antigrippal est recommandé chaque année pour réduire le risque."
}
},
{
"@type": "Question",
"name": "Comment éviter la transmission du COVID-19 ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Porter un masque, se laver les mains et se faire vacciner sont essentiels."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour prévenir l'hépatite A ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Vaccination et hygiène alimentaire sont cruciales pour prévenir l'hépatite A."
}
},
{
"@type": "Question",
"name": "Comment prévenir la varicelle ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination est le moyen le plus efficace de prévenir la varicelle."
}
},
{
"@type": "Question",
"name": "Quels traitements pour le VIH ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antirétroviraux sont utilisés pour contrôler l'infection par le VIH."
}
},
{
"@type": "Question",
"name": "Comment traiter une grippe ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antiviraux comme l'oseltamivir peuvent réduire la durée des symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il un traitement pour l'hépatite C ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antiviraux à action directe peuvent guérir l'hépatite C."
}
},
{
"@type": "Question",
"name": "Comment traiter une infection à coronavirus ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des antiviraux et des soins de soutien selon la gravité."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements pour la varicelle ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antihistaminiques et des antiviraux peuvent soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Quelles complications de l'hépatite B ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cirrhose et cancer du foie peuvent survenir chez les patients chroniques."
}
},
{
"@type": "Question",
"name": "Quelles complications du virus Ebola ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles hémorragiques et des défaillances organiques."
}
},
{
"@type": "Question",
"name": "Quels risques liés à la grippe ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des pneumonies et des exacerbations d'asthme peuvent survenir chez les vulnérables."
}
},
{
"@type": "Question",
"name": "Quelles complications du COVID-19 ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des problèmes respiratoires chroniques et des troubles neurologiques peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Quelles complications de la varicelle ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Infections bactériennes secondaires et pneumonie peuvent survenir chez les adultes."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour le VIH ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les rapports non protégés et l'utilisation de drogues injectables augmentent le risque."
}
},
{
"@type": "Question",
"name": "Qui est à risque de grippe sévère ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées, les jeunes enfants et les immunodéprimés sont plus à risque."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'hépatite C ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'utilisation de drogues injectables et les transfusions sanguines non sécurisées sont des risques."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour le COVID-19 ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé, les maladies chroniques et l'obésité augmentent le risque de complications."
}
},
{
"@type": "Question",
"name": "Qui est à risque de varicelle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes non vaccinées et celles ayant un système immunitaire affaibli sont à risque."
}
}
]
}
]
}
Antibody-mediated rejection (AMR) is the major cause of graft loss in kidney transplant recipients. The Banff classification defines two classes of AMR, active and chronic active but over time this cl...
In intestinal transplantation, while other centers have shown that liver-including allografts have significantly more favorable graft survival and graft loss-due-to chronic rejection (CHR) rates, our ...
Understanding immune cell dynamics in kidney transplantation may provide insight into the mechanisms of rejection and improve patient management. B cells have gained interest with a special relevance ...
We employed flow cytometry and qPCR techniques to characterize B and T cell subsets within fresh whole blood samples, with particular emphasis on transitional B cells (TrB) identified as CD19...
Higher percentages of TrB cells at 3 months after transplantation were positively associated with better graft outcomes and lower biopsy-proven acute rejection risk. Furthermore, a novel panel of B ce...
These findings suggest that monitoring TrB may provide interesting patient management information, improve transplant outcomes, and allow for personalized drug regimens to minimize clinical complicati...
The aim of the study was to present the rates of corneal transplant rejection from 2018 to 2022 at both Moorfields Eye Hospital UK, and Ospedali Privati Forli (OPF) "Villa Igea", Italy and evaluate th...
We performed a retrospective review of rejection cases presenting to the two units. Monthly rates were correlated against regional vaccination programme rates. At OPF, conditional Poisson regression m...
Between January 2018 and March 2022, there were 471 (Moorfields), 95 (OPF) episodes of rejection. From the start of vaccination programme in the UK in late January 2021, the median number of graft rej...
No notable increase in rates of transplant rejection was noted in year 2021 when COVID-19 vaccination was broadly implemented. The apparent temporal relationship between COVID-19 vaccination and corne...
The study aimed to investigate the impact of HLA-DPB1 allelic and molecular mismatches on the occurrence of acute rejection (AR) and low 5-year graft function (5Y-GF) in first kidney transplant (KT) r...
Intestinal transplantation is a life-saving procedure utilized for patients failing total parenteral nutrition. However, intestinal transplantattion remains plagued with low survival rates and high ri...
Graft survival is mainly determined by rejections and infectious complications in transplant recipients. Torque Teno Virus (TTV), a nonpathogenic and ubiquitous single-stranded DNA virus, has been pro...
Prospective cohort study on 107 adult renal transplant recipients. TTV viral load was determined in 746 plasma samples collected before and after renal transplantation by a Home-Brew PCR and a commerc...
Agreement of both PCR assays was 93.2% and Pearson correlation coefficient was r: 0.902 (95%CI: 0.8881-0.9149, p < 0.0001). TTV viral load kinetics showed an initial gradual increase reaching a peak a...
Significantly lower TTV viral load was observed in patients with renal rejection occurring at a median of 243 days post-transplantation. Given the dynamic behavior of TTV viral load post-transplantati...
Despite major advances in immunosuppression, allograft rejection remains an important complication after heart transplantation, and it is associated with increased morbidity and mortality. The gold st...
Solid organ transplantation is a life-saving treatment for people with end-stage organ disease. Immune-mediated transplant rejection is a common complication that decreases allograft survival. Althoug...
Mesenchymal stem cell (MSCs) therapy has already been studied in kidney transplant recipients (KTRs), and the available data showed that it is safe and well tolerated. The aim of this study was to eva...